Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-29

Clinical Trial Update: Trifecta™ GT Post Market Clinical Follow-up [NA]

View source ↗

Summary

Post-market clinical follow-up update for the Trifecta GT aortic valve, with the PMCF completed and results posted in May 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trifecta GT

Snippet

Sponsor: Abbott Medical Devices | Conditions: Aortic Valve Disease, Aortic Valve Disorder | NA | Status: COMPLETED | Results posted: 2024-05-29